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Accepted 9 September 2014Encapsulating peritoneal sclerosis (EPS) is a rare, but often fatal,
complication of peritoneal dialysis, characterized by marked
inﬂammation and severe ﬁbrosis of the peritoneum. Thick adhe-
sions resembling a cocoon encapsulate the intestinal loops. Hence,
this condition is also referred to as “abdominal cocooning”. EPS
usually occurs after long periods of peritoneal dialysis. Patients
with EPS demonstrate nonspeciﬁc symptoms such as bowel
obstruction, loss of appetite, fever, nausea, vomiting, ascites, con-
stipation, diarrhea, and weight loss. The diagnosis of EPS is usually
made by computed tomography (CT) scan. Another ancillary pro-
cedure is peritoneoscopy. During laparotomy, the classic picture of
abdominal cocooning is seen [1e8]. We present a case of a 65-year-
old woman, gravida 4 para 3, who was operated with the impres-
sion of ovarian malignancy based on the imaging survey, but found
to have EPS with hemorrhagic necrosis.
A 65-year-old woman, gravida 4 para 3, who was in menopause
for 18 years, was admitted for vaginal spotting and abdominal
distention. Physical examination revealed an abdominalepelvic
mass extending up to the level of the umbilicus. She was also noted
to have nonspeciﬁc symptoms such as nausea, constipation, and
poor appetite for the past number of years. The patient was diag-
nosed with end-stage renal disease for diabetic nephropathy. She
had been on peritoneal dialysis for 13 years, but has been on he-
modialysis for the past 4 years.
On admission, the patient was weak and pale, but alert.
Abdominal examination revealed a soft, tympanic abdomen with
hypoactive bowel sounds. On palpation, the mass extended up to* Corresponding author. Department of Obstetrics and Gynecology, Chang Gung
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There was no guarding or rigidity. The CA-125 level was 72.8 U/mL.
Transvaginal ultrasound showed a large pelvic mass with thick
conﬂuent septum and scattered calciﬁcations, but the origin could
not be speciﬁed (Fig. 1). The initial impression was an ovarian tu-
mor. CT scan revealed a centrally necrotic cystic mass measuring
19.7 cm  16 cm, with irregular borders and calciﬁcations.
Dilated bowel loops were pushed to the peripheral portion of
the abdominal wall (Fig. 2). Several soft tissue lesions were noted
on the peripheral portion of the mass. Another cystic mass with
calciﬁcations measuring 12 cm at the anterior hepatic surface was
also noted. The uterus was anteverted, and other adnexal structures
could not be clearly identiﬁed. No lymph node enlargement was
noted.
Under the impression of ovarian cancer, laparoscopic staging
surgery was planned. The view from the laparoscope showed the
parietal peritoneum and the ﬁbrous bands that covered the bowel
(Fig. 3). The laparoscopic approach had to be abandoned, as
adequate pneumoperitoneum could not be created because the
parietal peritoneum was seen loosely adherent to the bowel and
omentum like a ﬂimsy membrane. Intestinal loops were encapsu-
lated together by thick adhesions. Conversion to laparotomy was
performed. Upon opening, there was a white, thick-walled cyst
measuring 30 cm in diameter, which was densely adherent to the
bowel. During the removal of the mass, hemorrhagic ﬂuid was
drained. There were dense adhesions between the bowel, perito-
neum, uterus, and adnexa. The uterus and the left adnexa appeared
atrophic. During adhesiolysis, a Grade IV laceration was acciden-
tally created over the proximal jejunum, which was later repaired.
The bowels that were densely adherent to the mass were resected,
followed by end-to-end anastomosis. The patient recovered well
with postoperative nutritional support, and the symptoms
improved. She had a better postoperative status as compared to
that prior to surgery. Histopathology reports were compatible with
ﬁbrous tissue.
EPS is a rare and deadly complication that occurs after perito-
neal dialysis. The prevalence of EPS ranges from 0.54% to 7.3% [9].by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Transvaginal ultrasound of the large pelvic mass.
Fig. 2. CT scan image of abdomen demonstrating the centrally necrotic cystic mass
with peritoneal calciﬁcation (arrow). Note the dilated small bowel loops (‘’ symbol)
that was pushed to the peripheral abdominal wall. CT ¼ computed tomography.
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develop simple peritoneal sclerosis, but only few of them progress
to EPS. Kawanishi et al [4] reported a 4-year study from April 1999
to March 2003 involving 1958 patients undergoing peritoneal
dialysis. Forty-eight patients developed EPS after discontinuation of
peritoneal dialysis. This amounts to an overall incidence of 2.5%. It
was observed in the study that patients who were on peritoneal
dialysis for longer periods of time had a higher incidence of EPS.
Five of the 29 patients (17.2%) developed EPS after being on peri-
toneal dialysis for more than 15 years. The patient referred to here
has been on peritoneal dialysis for 13 years, thereby increasing the
possibility of EPS.Fig. 3. Initial laparoscopy picture showing the parietal peritoneum (P) and the
encapsulated thick ﬁbrous adhesions (A) that was encapsulating the bowel.
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EPS. At the early stage of EPS, ultrasound will show some abnor-
malities in small-bowel peristalsis, tethering of the bowel posteri-
orly, and ﬁne echogenic strands or membrane formation adherent
to major organs or to the anterior abdominal wall. In the advanced
stage, a characteristic trilaminar appearance around the bowel can
be seen [8]. Pathologic features that are diagnostic of EPS include
peritoneal thickening and calciﬁcation, loculated ascites, narrowing
bowel lumen with adherent loops, and encapsulation by a ﬁbrous
cocoon [1]. Triga [2] describes three phases of EPS: inﬂammation,
calciﬁcation, and sclerosis. The patient exhibits the inﬂammatory
phase with nonspeciﬁc symptoms such as abdominal pain,
anorexia, nausea, diarrhea, and weight loss [2]. Laboratory ﬁndings
include elevated C-reactive protein and TGFb1, anemia, hypo-
albuminemia, and raised CA-125 levels. It must be considered that
our patient showed elevated CA-125 levels. CT scan ﬁndings sug-
gestive of EPS are peritoneal enhancement or thickening, calciﬁ-
cations, bowel tethering or dilatation, and ﬂuid loculation [10].
When three of the four ﬁndings are evident, EPS is highly sus-
pected. In our patient, calciﬁcations and bowel dilatation were
noted.
In retrospect, the authors should have had a high degree of
suspicion for EPS, given the long period of peritoneal dialysis that
the patient was exposed to. However, nonspeciﬁc symptoms such
as anorexia, nausea, weight loss, a huge pelviceabdominal mass
with calciﬁcations, and a high CA-125 level are all highly suggestive
of ovarian cancer.
Morbidity and mortality are still high for cases of EPS. In the
study of Kawanishi et al [4], all ﬁve patients who developed EPS
after being on peritoneal dialysis for more than 15 years had 100%
mortality. Nutritional assessment and support are of primary
importance. Careful nutritional management plays a very impor-
tant role. Owing to its rarity, a standard surgical treatment for EPS
has not been established.
Diagnosis and treatment of EPS requires a multidisciplinary
approach. The possibility of EPS has to be entertained when apatient presents with a history of peritoneal dialysis and has
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